NCT01679756

Brief Summary

The aim of this systematic review is to compare intracorporeal (IA) versus extracorporeal anastomosis (EA) after laparoscopic right hemicolectomy for cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
384

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Mar 2013

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 6, 2012

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

September 6, 2012

Status Verified

September 1, 2012

Enrollment Period

1 year

First QC Date

September 1, 2012

Last Update Submit

September 1, 2012

Conditions

Keywords

Colorectal cancerLaparoscopic right hemicolectomyIntracorporeal anastomosis

Outcome Measures

Primary Outcomes (1)

  • Overall surgical morbidity

    Surgical morbidity rate defined as any diagnosed morbidity related to surgical technique (anastomotic leakage, anastomotic bleeding, wound infection, ileus) within 60 days from surgery.

    60 days from surgery

Secondary Outcomes (14)

  • Operative time

    day of intervention

  • Largest incision length

    day of intervention

  • Numbers of node harvested

    day of intervention

  • Intraoperative complicatons

    day of intervention

  • Mortality

    60 days from surgery

  • +9 more secondary outcomes

Study Arms (2)

Intracorporeal anastomosis

EXPERIMENTAL

Laparoscopic right hemicolectomy for cancer. .For the IA group, colon, transverse mesocolon, ileum and terminal ileum mesentery will be resected intracorporeally through a 45 mm endoscopic linear stapler with vascular cartridge. Then, the linear stapler will inserted through two small enterotomies and a mechanical ileo-transverse, side-to-side isoperistaltic intracorporeal anastomosis performed using the vascular cartridge with six rows of closely placed staples. The enterotomies will be then closed using a double layered continuous intra corporeal manual suture with 3-0 Polyglactin 910. The mesenteric defects will be left open. The specimen will be placed in a protective plastic bag and then extracted through a Pfannestiel incision.

Procedure: Laparoscopic right hemicolectomy for cancer

Extracorporeal anastomosis

ACTIVE COMPARATOR

Laparoscopic right hemicolectomy for cancer. In the EA group, the bowel will be externalized by widening the incision of one of the trocars or by performing a mini-laparotomy at another location (subcostal, suprapubic) protected with a plastic sheet. The ileum and colon will be then resected through a 45 mm endoscopic linear stapler with vascular cartridge (staple height = 3.85 mm) and a side-to-side isoperistaltic mechanical anastomosis will be then performed using the same vascular cartridge. The enterotomies will be then closed using a double layered continuous manual suture using a 3-0 Polyglactin 910. In both groups, a drain will not routinely inserted.

Procedure: Laparoscopic right hemicolectomy for cancer

Interventions

After induction of anesthesia, a foley catheter and an NG tube will be inserted. All patients will have their NG tubes removed after the procedure. During the procedure patients will be placed in Trendelenburg position with 15 degrees of tilt and with a right side up (tilt to the left of 25 degrees). A Veres needle will be inserted and pneumoperitoneum induced and maintained at 12 mmHg for the entire duration of the procedure. Under direct vision, three 10-12mm trocars will be inserted in the left abdominal wall. The ileocolic vessels, the right colic vessels (when present), the right branch of the middle colic vessels and the right gastroepiploic vessels will be ligated intracorporeally at their origin using clips. Anastomosis are described in each arm description.

Extracorporeal anastomosisIntracorporeal anastomosis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suitable for curative surgery 18-80 years old
  • ASA grade I-III
  • Histhopatological confirmed right only colon carcinoma.
  • Elective interventions
  • Laparoscopic surgery
  • Informed consent

You may not qualify if:

  • Informed consent refusal
  • Metastatic disease
  • Not right colon cancer
  • Non elective procedure
  • Open or converted operations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Misericordia e Dolce Hospital

Prato, Po, 59100, Italy

Location

Related Publications (1)

  • Scatizzi M, Kroning KC, Borrelli A, Andan G, Lenzi E, Feroci F. Extracorporeal versus intracorporeal anastomosis after laparoscopic right colectomy for cancer: a case-control study. World J Surg. 2010 Dec;34(12):2902-8. doi: 10.1007/s00268-010-0743-6.

    PMID: 20703468BACKGROUND

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Marco Scatizzi, MD

    Misericordia e Dolce Hospital

    STUDY CHAIR
  • Francesco Feroci, MD

    Misericordia e Dolce Hospital

    STUDY DIRECTOR
  • Stefano Cantafio, MD

    Misericordia e Dolce Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francesco Feroci, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 1, 2012

First Posted

September 6, 2012

Study Start

March 1, 2013

Primary Completion

March 1, 2014

Study Completion

June 1, 2014

Last Updated

September 6, 2012

Record last verified: 2012-09

Locations